In contrast, GSH-low cells (HCC70 and MDA-MB-436) and a HER2-amplified basal breast cancer cell line (HCC1954) showed substantial antagonism (Supplementary Fig. 3f–h), likely due to their limited dependency on the GSH pathway. This evidence concerns the gene ERBB2 and breast carcinoma.